NCT00239889View on ClinicalTrials.gov

Efficacy and Safety of Salmon Calcitonin Nasal Spray in Improving Muscle Strength and Reducing Pain After Forearm Fracture in Postmenopausal Women

PHASE4CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

March 31, 2002

Conditions
Forearm Fracture
Interventions
DRUG

Salmon calcitonin

Trial Locations (2)

Unknown

Novartis, Nuremberg

Novartis, Basel

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00239889 - Efficacy and Safety of Salmon Calcitonin Nasal Spray in Improving Muscle Strength and Reducing Pain After Forearm Fracture in Postmenopausal Women | Biotech Hunter | Biotech Hunter